By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ensysce Biosciences Inc. 

1430 O'Brien Drive
Suite G
Menlo Park  California  94025  U.S.A.
Phone: n/a Fax: n/a



Start Up

Company News
Ensysce Biosciences Inc. And Signature Therapeutics Merger 1/19/2016 9:45:21 AM
Ensysce Biosciences Inc. Demonstrates Carbon Nanotube Delivery Of RNA To PBMCs 7/8/2015 12:05:42 PM
Ensysce Biosciences Inc. Receives Notice Of Allowance For U.S. Patent For Delivery Of siRNA 3/7/2014 8:51:24 AM
Ensysce Biosciences Inc. Receives Small Business Grant From National Institutes of Health (NIH) to Optimize Single Walled Carbon Nanotube Formulation for Therapeutic Delivery of siRNA 9/25/2012 10:02:30 AM
Ensysce Biosciences Inc. Completes Qualifying Financial Transaction Matching Emerging Technology Funds from the State of Texas 6/6/2012 9:57:07 AM
Ensysce Biosciences Inc. Publishes Data on the Use of Carbon Nanotube to Aid the Delivery of siRNA 2/14/2012 6:01:17 AM
Ensysce Biosciences Inc. Raises $1.5 Million 6/14/2010 8:24:12 AM
Ensysce Biosciences Inc. Receives Emerging Technology Funds from the State of Texas 6/11/2010 10:28:38 AM
Ensysce Biosciences Inc. Appoints Dr. D. Lynn Kirkpatrick as President and CEO 1/5/2009 6:53:19 AM
Unidym, Inc. Spins off Ensysce Biosciences Inc. to Pursue Medical Therapeutic Applications of Carbon Nanotubes 3/18/2008 8:21:34 AM